BR0017028A - Lipopepìdeos como agentes antibacterianos - Google Patents

Lipopepìdeos como agentes antibacterianos

Info

Publication number
BR0017028A
BR0017028A BR0017028-3A BR0017028A BR0017028A BR 0017028 A BR0017028 A BR 0017028A BR 0017028 A BR0017028 A BR 0017028A BR 0017028 A BR0017028 A BR 0017028A
Authority
BR
Brazil
Prior art keywords
compounds
antibacterial agents
lipopeptides
relates
methods
Prior art date
Application number
BR0017028-3A
Other languages
English (en)
Inventor
Jason Hill
Ian Parr
Michael Morytko
Jim Siedlecki
Xiang Yang Yu
Jared Silverman
Dennis Keith
John Finn
Dale Christensen
Tsvetelina Lazarova
Alan D Watson
Yan Zhang
Original Assignee
Cubist Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cubist Pharm Inc filed Critical Cubist Pharm Inc
Publication of BR0017028A publication Critical patent/BR0017028A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"LIPOPEPTìDEOS COMO AGENTES ANTIBACTERIANOS". A presente invenção se refere a novos compostos de lipopeptídeos. A invenção também se refere a composições farmacêuticas destes compostos e métodos de uso destes compostos como compostos antibacterianos. A invenção também se refere a métodos para produzir estes novos compostos de lipopeptídeos e intermediários usados na produção destes compostos.
BR0017028-3A 1999-12-15 2000-12-15 Lipopepìdeos como agentes antibacterianos BR0017028A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17094599P 1999-12-15 1999-12-15
PCT/US2000/034051 WO2001044271A2 (en) 1999-12-15 2000-12-15 Daptomycin analogs and their use as antibacterial agents

Publications (1)

Publication Number Publication Date
BR0017028A true BR0017028A (pt) 2003-01-07

Family

ID=22621920

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0017028-3A BR0017028A (pt) 1999-12-15 2000-12-15 Lipopepìdeos como agentes antibacterianos

Country Status (13)

Country Link
US (1) US6794490B2 (pt)
EP (1) EP1240182A2 (pt)
JP (1) JP2003517003A (pt)
KR (1) KR20020063230A (pt)
CN (1) CN1423655A (pt)
AU (1) AU784942B2 (pt)
BR (1) BR0017028A (pt)
CA (1) CA2394313A1 (pt)
IL (1) IL150224A0 (pt)
MX (1) MXPA02006028A (pt)
NO (1) NO20022886L (pt)
WO (1) WO2001044271A2 (pt)
ZA (1) ZA200205113B (pt)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0016467A (pt) * 1999-12-15 2002-08-27 Cubist Pharm Inc Lipopeptìdeos como agentes antibacterianos
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
CA2301336A1 (en) * 2000-03-17 2001-09-17 Michael T. Kelly Topical treatment of rosacea
NZ571597A (en) 2000-12-18 2010-05-28 Cubist Pharm Inc Method for preparing crystalline and crystal-like forms of purified daptomycin lipopeptides
US20060014674A1 (en) 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
DE60232158D1 (de) 2001-08-06 2009-06-10 Cubist Pharm Inc Lipopeptid-stereoisomere, verfahren zu ihrer herstellung und nützliche zwischenprodukte
EP1932853A1 (en) 2001-08-06 2008-06-18 Cubist Pharmaceutical Inc. Novel depsipeptides and process for preparing same
US6767718B2 (en) 2002-05-10 2004-07-27 Biosource Pharm, Inc. Lipodepsipeptide antibiotics and methods of preparation
US20090149453A1 (en) * 2002-05-23 2009-06-11 Activbiotics Pharma Llc Methods and compositions for treating bacterial infections and diseases associated therewith
AU2003265241A1 (en) * 2002-05-23 2003-12-12 Activbiotics, Inc. Methods of treating bacterial infections and diseases associated therewith
US20040077533A1 (en) * 2002-05-23 2004-04-22 Sayada Chalom B. Methods and compositions for treating bacterial infections and diseases associated therewith
AU2003240545A1 (en) 2002-06-06 2003-12-22 Therapeutics Corporation Genome Use of ramoplanin to treat diseases associated with the use of antibiotics
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
CA2529125A1 (en) * 2003-06-19 2004-12-23 Yeda Research & Development Co. Ltd. Antimicrobial and anticancer lipopeptides
EP1675548A4 (en) * 2003-09-25 2008-08-13 Activbiotics Inc RIFALAZIL FORMULATIONS
US20080019955A1 (en) * 2003-12-30 2008-01-24 Bioactive Polymers Ab Surface Protection of Exposed Biological Tissues
SE0303588D0 (sv) 2003-12-30 2003-12-30 Bioactive Polymers Ab C O Lund Surface protection of exposed biological tissues
US8782654B2 (en) 2004-03-13 2014-07-15 Adaptive Computing Enterprises, Inc. Co-allocating a reservation spanning different compute resources types
US8413155B2 (en) 2004-03-13 2013-04-02 Adaptive Computing Enterprises, Inc. System and method for a self-optimizing reservation in time of compute resources
US20070266388A1 (en) 2004-06-18 2007-11-15 Cluster Resources, Inc. System and method for providing advanced reservations in a compute environment
US20060004185A1 (en) 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
US8176490B1 (en) 2004-08-20 2012-05-08 Adaptive Computing Enterprises, Inc. System and method of interfacing a workload manager and scheduler with an identity manager
WO2006053093A2 (en) 2004-11-08 2006-05-18 Cluster Resources, Inc. System and method of providing system jobs within a compute environment
CA2587848A1 (en) * 2004-11-12 2006-10-19 Cubist Pharmaceuticals, Inc. Antiinfective lipopeptides
US20080051326A1 (en) * 2004-11-12 2008-02-28 Alexander Dylan C Antiinfective Lipopeptides
JP2008534444A (ja) * 2005-03-10 2008-08-28 スミスクライン・ビーチャム・コーポレイション 新規な方法
US8863143B2 (en) 2006-03-16 2014-10-14 Adaptive Computing Enterprises, Inc. System and method for managing a hybrid compute environment
WO2006107531A2 (en) 2005-03-16 2006-10-12 Cluster Resources, Inc. Simple integration of an on-demand compute environment
US9231886B2 (en) 2005-03-16 2016-01-05 Adaptive Computing Enterprises, Inc. Simple integration of an on-demand compute environment
CA2603577A1 (en) 2005-04-07 2006-10-12 Cluster Resources, Inc. On-demand access to compute resources
AU2006242535B2 (en) * 2005-04-29 2012-08-09 Merck Sharp & Dohme Corp. Therapeutic compositions
EP2018864A1 (en) 2007-07-23 2009-01-28 Biomet Deutschland GmbH Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition
US8041773B2 (en) 2007-09-24 2011-10-18 The Research Foundation Of State University Of New York Automatic clustering for self-organizing grids
PL2379580T3 (pl) * 2008-12-22 2014-05-30 Merck Sharp & Dohme Nowe środki przeciwbakteryjne do leczenia zakażeń wywołanych bakteriami Gram-dodatnimi
NZ593892A (en) 2008-12-23 2013-11-29 Biosource Pharm Inc Antibiotic compositions for the treatment of gram negative infections
US10877695B2 (en) 2009-10-30 2020-12-29 Iii Holdings 2, Llc Memcached server functionality in a cluster of data processing nodes
US11720290B2 (en) 2009-10-30 2023-08-08 Iii Holdings 2, Llc Memcached server functionality in a cluster of data processing nodes
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
WO2012011917A1 (en) * 2010-07-23 2012-01-26 Activbiotics Pharma, Llc Administration of rifalazil to immunocompromised patients
MX2013013760A (es) * 2011-05-26 2014-01-08 Cubist Pharm Inc Composiciones de cb-183, 315 y metodos relacionados.
EP3384938A1 (en) 2011-09-12 2018-10-10 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
US8461188B2 (en) 2011-10-20 2013-06-11 Trius Therapeutics, Inc. Therapeutic combination of daptomycin and protein synthesis inhibitor antibiotic, and methods of use
AU2013243949A1 (en) 2012-04-02 2014-10-30 Moderna Therapeutics, Inc. Modified polynucleotides for the production of biologics and proteins associated with human disease
EP2833923A4 (en) 2012-04-02 2016-02-24 Moderna Therapeutics Inc MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS
KR20180101341A (ko) 2015-11-10 2018-09-12 비스테라, 인크. 리포폴리사카라이드에 특이적으로 결합하는 항체 분자-약물 접합체 및 그의 용도
US10358463B2 (en) * 2016-04-05 2019-07-23 Bristol-Myers Squibb Company Immunomodulators
EP3571223B1 (en) 2017-01-18 2024-09-18 Visterra, Inc. Antibody molecule-drug conjugates and uses thereof
WO2018237153A1 (en) * 2017-06-23 2018-12-27 Bristol-Myers Squibb Company IMMUNOMODULATORS ACTING AS PD-1 ANTAGONISTS
JP2023521319A (ja) 2020-04-03 2023-05-24 ビステラ， インコーポレイテッド 抗体分子－薬物コンジュゲートおよびその使用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL68700A0 (en) 1982-05-21 1983-09-30 Lilly Co Eli Improvements relating to a-21978c cyclic peptide derivatives and their production
US4482487A (en) 1982-05-21 1984-11-13 Eli Lilly And Company A-21978C cyclic peptides
US4524135A (en) 1982-05-21 1985-06-18 Eli Lilly And Company A-21978C cyclic peptides
USRE32310E (en) 1982-05-21 1986-12-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4399067A (en) 1982-05-21 1983-08-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4396543A (en) 1982-05-21 1983-08-02 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
USRE32311E (en) 1982-05-21 1986-12-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4537717A (en) 1982-05-21 1985-08-27 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
ZA883887B (en) 1987-06-10 1990-02-28 Lilly Co Eli Chromatographic purification process
ES2089133T3 (es) 1990-06-07 1996-10-01 Lilly Co Eli Desacilasa de lipopeptidos.
DE4411025A1 (de) 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
ATE544851T1 (de) 1996-03-08 2012-02-15 Astellas Pharma Inc Verfahren zur deacylierung von zyklischen lipopeptiden
DE19807972A1 (de) 1998-02-25 1999-08-26 Hoechst Marion Roussel De Gmbh Lipopeptidantibiotika-Calciumsalze, Verfahren zu ihrer Herstellung und Verwendung

Also Published As

Publication number Publication date
JP2003517003A (ja) 2003-05-20
AU3264001A (en) 2001-06-25
WO2001044271A2 (en) 2001-06-21
NO20022886L (no) 2002-08-02
CA2394313A1 (en) 2001-06-21
MXPA02006028A (es) 2004-08-23
KR20020063230A (ko) 2002-08-01
US6794490B2 (en) 2004-09-21
EP1240182A2 (en) 2002-09-18
US20020058785A1 (en) 2002-05-16
CN1423655A (zh) 2003-06-11
AU784942B2 (en) 2006-08-03
NO20022886D0 (no) 2002-06-17
ZA200205113B (en) 2003-11-26
WO2001044271A3 (en) 2002-03-07
IL150224A0 (en) 2002-12-01

Similar Documents

Publication Publication Date Title
BR0017028A (pt) Lipopepìdeos como agentes antibacterianos
BR0017026A (pt) Lipeptìdeos como agentes antibacterianos
BR0016467A (pt) Lipopeptìdeos como agentes antibacterianos
UY27368A1 (es) Nuevos compuestos
BR0114316A (pt) Processo para a preparação de formulações em pó
AR023574A1 (es) Compuestos de azepinindol tetraciclico,composiciones farmaceuticas y el uso de dichos compuestos para preparar un medicamento, e intermediarios
PA8551001A1 (es) Nuevos compuestos
DE60038183D1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
AR037517A1 (es) Derivados de naftiridinas, un proceso para su preparacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento para el tratamiento de una enfermedad inflamatoria
AR024060A1 (es) Nuevos compuestos farmaceuticamente activos
SE0100569D0 (sv) New compounds
PA8525001A1 (es) Compuestos de 1,4-dihidropiridina como antagonistas de bradicinina
BRPI0406717A (pt) Composto, composição farmacêutica que compreende o mesmo, método de tratamento de uma enfermidade em um mamìfero, utilização do composto e processo para a sua produção
EP1423137A4 (en) STEREO-ISOMERS OF LIPOPEPTIDE, METHODS OF PREPARATION AND USEFUL INTERMEDIATES
UY27593A1 (es) Nuevos compuestos
GT200000001A (es) Derivados de eter propargilico novedosos.
SE9901077D0 (sv) Novel use
BR0315663A (pt) Formulações de depósito de agentes ativos de aril-heterocìclicos na forma de uma suspensão
UY27980A1 (es) Indoles 2,7-sustituidos
SE0102440D0 (sv) New compound
AR030788A1 (es) Antagonistas de receptores de taquiquinina zwitterionica
PA8509601A1 (es) "PIRAZOLO [4,3,e] DIAZEPINAS SUSTITUIDAS NOVEDOSAS, COMPOSICIONES FARMACEUTICAS QUE LAS CONTIENEN, SU USO COMO PRODUCTOS MEDICINALES Y PROCESOS PARA PREPARARLAS
PT1347960E (pt) Processo para a preparacao de (+)-trans-4-p-fluorofenil-3-hidroximetil-1-metilpiperidina
BR0207077A (pt) Sais de adição do ácido málico da terbinafina
AR046212A1 (es) Derivados de 2-fenilbenzofurano, procedimiento para su preparacion y composiciones farmaceuticas que los contienen

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A, E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1929 DE 26/12/2007.